What is NovoCure's change in other liabilities?

NovoCure (NVCR) reported change in other liabilities of -$2.84M in Q1 2026.

How has NovoCure's change in other liabilities changed year-over-year?

NovoCure's change in other liabilities decreased by 153.1% year-over-year, from -$1.12M to -$2.84M.

What is the long-term trend for NovoCure's change in other liabilities?

Over 4 years (2021 to 2025), NovoCure's change in other liabilities has grown at a -16.7% compound annual growth rate (CAGR), from -$10.98M to -$5.27M.

What does change in other liabilities mean?

Change in miscellaneous liabilities affecting operating cash flow.

NovoCure NVCR Change in Other Liabilities

Change in Other Liabilities at other companies

BridgeBio PharmaBBIO

$4.62M+56.8%

Jazz PharmaceuticalsJAZZ

$12.2M+321%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Enterprise value$1.66B-36.3%

P/S2.5×-1.8×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's change in other liabilities?: NovoCure (NVCR) reported change in other liabilities of -$2.84M in Q1 2026.
How has NovoCure's change in other liabilities changed year-over-year?: NovoCure's change in other liabilities decreased by 153.1% year-over-year, from -$1.12M to -$2.84M.
What is the long-term trend for NovoCure's change in other liabilities?: Over 4 years (2021 to 2025), NovoCure's change in other liabilities has grown at a -16.7% compound annual growth rate (CAGR), from -$10.98M to -$5.27M.
What does change in other liabilities mean?: Change in miscellaneous liabilities affecting operating cash flow.